BLUU's marine cells are cultivated in a controlled production environment rather than sourced continuously from marine ecosystems or aquaculture. This avoids exposure to microplastics from marine sourcing and does not require antibiotics in the production process.
Instead of continuously sourcing biological material through wild catch or aquaculture, BLUU cultivates marine cells under controlled conditions. This reduces dependence on geography, seasonality and variable natural inputs, enables more predictable and traceable production, and removes the need for ongoing wild catch or aquaculture as a raw-material source.
BLUU operates within defined process windows supported by documentation, quality systems and traceability. Controlled inputs and monitored process parameters support consistent biological outputs and partner-specific evaluation requirements. BLUU works closely with partners to ensure high quality.
BLUU's process is designed around control and repeatability as volumes increase. The cultivation process has already been successfully scaled to 1,000-liter bioreactors, and reproducibility has been demonstrated across different facilities and bioreactor types.
Consistency is achieved through controlled bioprocessing, defined inputs and monitored process parameters. This reduces variability and supports repeatable specifications across production runs.
No. BLUU uses robust non-GMO cell lines selected for stable biological behavior and long-term repeatability under controlled cultivation conditions.
No repeated animal use is required after the original cell sourcing. BLUU's cell lines can be cultivated and expanded in controlled bioreactor systems without ongoing harvesting of animals.
BLUU's cells originate from a single biopsy of a salmonid fish. The cells were isolated in a one-time process and can subsequently be cultivated and expanded without repeated animal sourcing.
BLUU's marine ingredient platform starts with stable salmonid cell lines that are cultivated under defined and monitored conditions. The resulting biological material is concentrated and processed into defined components and bio-actives for partner evaluation and application development.
Marine biomanufacturing refers to producing biological materials under controlled conditions rather than relying on seasonal harvesting or extraction from natural sources.
Most partners begin with material characteristics, consistency, and documentation relevant to their specific application context.
Core biological systems and process know-how are proprietary. Documentation and data are shared progressively during partner evaluation.
BLUU works with partners during ingredient development, evaluation, application testing and development. Components and bio-actives are designed for partner evaluation, with technical information and data shared progressively as collaborations advance.
BLUU develops ingredient components with integration into existing personal care formulation systems in mind. Specific incorporation levels, formulation compatibility and technical requirements depend on the individual ingredient and partner application.
By definition, BLUU's ingredients are not vegan, as they are derived from animal cells. After the one-time initial cell sourcing, however, no further animals are used or harvested for production.
Toxicological and efficacy studies are performed by external, independent laboratories.
In initial in vitro safety testing according to OECD guidelines, the tested BLUU materials showed no toxicity in the evaluated models. The test battery covers cytotoxicity, skin irritation, eye irritation, skin sensitization, mutagenicity and genotoxicity. Additional analyses showed no heavy-metal impurities.
Early in vitro testing indicates, among other effects, ECM-protective and antioxidative activity for tested BLUU materials. These findings support further evaluation in personal care applications; they should not be interpreted as clinical efficacy in humans.
BLUU combines authentic marine cell biology with controlled biomanufacturing. Unlike conventional marine sourcing, production is independent of continuous harvesting, seasonality and geographical variability, while controlled process conditions support consistency, traceability and repeatability.
BLUU's salmonid cells are not an artificial reconstruction of a single molecule but a naturally co-expressed network of bioactive compounds, with more than 7,000 proteins and more than 4,000 metabolites.
Partners usually start with efficacy signals, stability, documentation quality, and how easily the ingredient fits into existing formulations.
Personal care is the first application area due to faster evaluation cycles and lower regulatory barriers, enabling early collaboration and validation of the platform.
BLUU develops marine bio-actives and ingredient components for high-performance personal care applications, including salmonid cell extracts. The platform provides access to a broad spectrum of marine proteins, peptides, fatty acids and other bioactive molecules. Depending on the collaboration, different products focusing on different molecule classes, such as proteins or lipids, can be developed.
The same fish-cell expertise that enables consistency in personal care and food can be applied to higher-barrier use cases where reliability and control are critical.
Health applications involve higher evidentiary and regulatory thresholds, requiring more structured evaluation and longer development timelines.
Development emphasizes documentation, reproducibility, and controlled production to support preclinical and early validation requirements.
BLUU develops bio-active components for evaluation and research collaboration; final medical product development is led by partners.
BLUU explores wound healing and regenerative applications where marine bio-actives may support tissue repair and biological signaling.
Food applications follow established regulatory pathways and are pursued in parallel with other markets, with timing dependent on jurisdiction and partner strategy.
Food applications leverage the same scalable bioprocessing principles as other verticals, with development guided by industrial volume requirements from the outset.
Instead of relying on wild catch or farming variability, BLUU produces ingredients under controlled conditions, improving supply reliability and predictability.
No. BLUU focuses on ingredient components. Product development and branding are led by partners.
BLUU supplies fish-cell-derived components that contribute to sensory, nutritional, or functional attributes in seafood-related products.